<DOC>
	<DOCNO>NCT02103686</DOCNO>
	<brief_summary>The purpose study : 1 . Compare pharmacokinetics profile pregabalin sustain release tablet ( 300mg ) immediate release capsule ( 150mg * 2 ) . 2 . Evaluate effectiveness food pharmacokinetics profile Pregabalin sustain release tablet .</brief_summary>
	<brief_title>Study Comparing The Pharmacokinetics A Pregabalin Controlled Release Tablet 300mg With Immediate Release Formulation Assess Effect High Fat Diet Healthy Male Subjects</brief_title>
	<detailed_description />
	<mesh_term>Pregabalin</mesh_term>
	<criteria>19~44 age healthy adult . someone tho least 50kg body weight ideal body weight Â±20 % someone acute symptom screen phase someone disease symptom clinically significant someone determine healthy examination screen period AST ALT &gt; 1.25 time normal Total bilirubin &gt; 1.5 time normal someone history allergy , anaphylaxis , drug abuse misuse . someone enrol clinical trial within last 60 day . someone donate blood within last 60 day . someone ca n't take meal derive trial . someone take abnormal meal like affect drug ADME someone take ETC drug oriental drug within last 14 day , Or OTC drug within last 7 day someone take caffein continuously ( coffee green tea 5 cup per day ) take caffein since 24hours . someone take alcohol 30g/day smoke 10 piece tobacco/day . someone galactose intolerance , Lapp lactase deficiency glucosegalactose malabsorption .</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>44 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Neuropathic pain</keyword>
	<keyword>pregabalin</keyword>
</DOC>